Joy Chinwendu Jacob

Joy Chinwendu Jacob

Auto-generated profile, based on publicly available information

Joy Chinwendu Jacob

Univ Lyon, Université Claude Bernard Lyon 1, 69100 Villeurbanne, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2022 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
CAClinton Njinju AMIN ASABA
Clinton Njinju AMIN ASABA
SHSodiq A. Hameed
Sodiq A. Hameed
EAEugene Kusi Agyei
Eugene Kusi Agyei
JJJoy Chinwendu Jacob
Joy Chinwendu Jacob
VOVictor Oyewale Oyebanji
Victor Oyewale Oyebanji
CJCyril Ekabe Jabea
Cyril Ekabe Jabea
In recent years, there has been ample evidence illustrating the effect of microbiota on gut immunity, homeostasis, and disease. Most of these studies have engaged more efforts in understanding the role of the bacteriome in gut mucosal immunity and disease. However, studies on the virome and its influence on gut mucosal immunity and pathology are still at infancy owing to limited metagenomic tools. Nonetheless, the existing studies on the virome have largely been focused on the bacteriophages as these represent the main component of the virome with little information on endogenous retroviruses (ERVs) and eukaryotic viruses. In this review, we describe the gut virome, and its role in gut mucosal response and disease progression. We also explore the crosstalk between the virome and other microorganisms in the gut mucosa and elaborate on how these interactions shape the gut mucosal immunity going from bacteriophages through ERVs to eukaryotic viruses. Finally, we elucidate the potential contribution of this crosstalk in the pathogenesis of inflammatory bowel diseases and colon cancer.